Godavari Drugs Ltd
Godavari Drugs Ltd Share Price Today: Live Updates & Key Insights
Get insights on Godavari Drugs Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Godavari Drugs Ltd Share Price Chart
GODAVARIDRUGS at 10 Jul 2026 05:31 PM Pharmaceuticals
123.00 +1.00(+0.82%)
Lowest Today 120.50
Highest Today 128.00
Today's Open 128.00
Prev. Close 122.00
52 Week High 135.25
52 Week Low 69.70
Godavari Drugs Ltd Fundamentals
Traded Volume: 1,319
Market Cap(Cr): 124.57
Avg Traded Price 121.82
1 Year return 37.92%
Upper Circuit 128
Lower Circuit 120.5
P/E TTM 0.00
P/B Ratio 1.630
Traded Value(Cr) 1.62
EPS TTM NaN
Book value/Share 74.840
Dividend Yield 1Y 0.00%
Godavari Drugs Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Godavari Drugs Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Godavari Drugs Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y +37.92%
YTD 0.00%
Godavari Drugs Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Godavari Drugs Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Godavari Drugs Ltd Technical Details
Godavari Drugs Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 120
Support 2 117
Support 3 115
Pivot Point : 122
Resistance 1 125
Resistance 2 127
Resistance 3 130
Godavari Drugs Ltd Corporate Actions
Godavari Drugs Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Godavari Drugs Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by GODAVARIDRUGS
Bonus
No Bonus has been declared by GODAVARIDRUGS
Splits
No Split has been declared by GODAVARIDRUGS
Others
Rights No Rights has been declared by GODAVARIDRUGS
Godavari Drugs Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Godavari Drugs Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Godavari Drugs Ltd's relative performance and valuation against major competitors.
Stock Name Lactose (India) Ltd ₹100.00 (+1.21%) M. Cap (Cr) 1.26 1 Yr Return (%) +1.16% P/E (TTM) 20.76 PB Ratio 1.94
Stock Name Tyche Industries Ltd ₹122.10 (+0.25%) M. Cap (Cr) 1.25 1 Yr Return (%) -14.41% P/E (TTM) 18.06 PB Ratio 0.89
Stock Name Bal Pharma Ltd ₹79.40 (+1.99%) M. Cap (Cr) 1.26 1 Yr Return (%) -20.54% P/E (TTM) 20.12 PB Ratio 1.54
Stock Name Godavari Drugs Ltd ₹123.00 (+0.82%) M. Cap (Cr) 1.25 1 Yr Return (%) +37.92% P/E (TTM) 30.46 PB Ratio 1.64
Stock Name Pharmaids Pharmaceuticals Ltd ₹35.00 (+3.58%) M. Cap (Cr) 1.23 1 Yr Return (%) -39.36% P/E (TTM) -10.53 PB Ratio 2.59
Stock Name Krebs Biochemicals & Industries Ltd ₹55.53 (-2.51%) M. Cap (Cr) 1.20 1 Yr Return (%) -33.55% P/E (TTM) -7.07 PB Ratio -0.74
Stock Name Sotac Pharmaceuticals Ltd ₹100.50 (-0.50%) M. Cap (Cr) 1.11 1 Yr Return (%) -22.60% P/E (TTM) 17.65 PB Ratio 1.89
Godavari Drugs Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Godavari Drugs Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 0.73 Mar 2025 11.20 Mar 2024 18.41 Mar 2023 13.22 Mar 2022 11.23
PARTICULARS Investing Activities Mar 2026 -25.95 Mar 2025 -19.51 Mar 2024 -13.22 Mar 2023 -8.64 Mar 2022 -4.97
PARTICULARS Financing Activities Mar 2026 37.35 Mar 2025 8.07 Mar 2024 -5.65 Mar 2023 -3.77 Mar 2022 -5.62
PARTICULARS Net Cash Flow Mar 2026 12.14 Mar 2025 -0.25 Mar 2024 -0.46 Mar 2023 0.81 Mar 2022 0.64
Godavari Drugs Ltd Shareholding Pattern
This shows the ownership breakdown of Godavari Drugs Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Godavari Drugs Ltd
Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India.. Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for API`s, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance value-addition. In fact, Siris and Chemox Chemicals, both having good capacities of SMX, have recently gone in for the production of SMO. In 2000 the company introduced `Pyrazyamide` in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of `Pyrazyamide` of 180 TPA and have also finalised on other products Cislactum,which is a intermediate used to produce Diltiazem an anti anginal drug. The Company combine their intrinsic strengths in chemistry with capabilities of process development, right from laboratory scale to pilot scale in pilot plant and finally manufacturing at the commercial scale in manufacturing facilities, which are in line with cGMP requirements. A combination of chemistry knowledge, with engineering strengths, along with good analytical backup enables Godavari Drugs to develop, scale, up and manufacture products right from laboratory to commercial scale.
Chairman(Non Exe)&Dir(Non-Ind)
Ghanshyam Jaju
Registered office Mayfair 1-8-303-34, Sardar Patel Road, Secunderabad, Andhra Pradesh, 500003
FAX :91-40-27849700/27844557
Background
Incorporation Year 1987
Face Value ₹10.00
Market Lot 1
FAQs on Godavari Drugs Ltd
How to buy Godavari Drugs Ltd shares?
To buy Godavari Drugs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Godavari Drugs Ltd?
The company has a market capitalization of ₹124.57.
What is the PE & PB ratio of Godavari Drugs Ltd?
PE is N/A and PB is 1.630.
What is the Godavari Drugs Ltd dividend for 2025–26?
For the 2025–26 financial year, Godavari Drugs Ltd declared a final dividend of null% per share.